STEVEN JAY FRANK to Kallikreins
This is a "connection" page, showing publications STEVEN JAY FRANK has written about Kallikreins.
Connection Strength
0.041
-
Dose Escalation for Prostate Adenocarcinoma: A Long-Term Update on the Outcomes of a Phase 3, Single Institution Randomized Clinical Trial. Int J Radiat Oncol Biol Phys. 2019 07 15; 104(4):790-797.
Score: 0.041